The ADC binds HER2 (not Top1), is internalized, and releases the DXd topoisomerase I inhibitor that causes DNA damage and apoptosis. DNA topoisomerase I is the intracellular enzymatic target of the payload, not the targeting antigen; any killing of Top1-expressing cells occurs only after HER2-mediated delivery or bystander diffusion.